The summary below was generated by an AI language model and may contain errors or omissions. All other content on this page is deterministically extracted from the original SEC EDGAR filing.
Elevance Health removed a general risk about negative publicity in the health benefits industry and added a more specific risk focused on data responsibility, protection, and reliability. The company substantially modified six risks, including heightened emphasis on information systems maintenance, data availability and integrity, and competitive pressures for workforce retention - reflecting a strategic shift toward technology and operational resilience concerns. With 19 risks unchanged, the modifications represent targeted refinements rather than a comprehensive restructuring of disclosed risk categories.
Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.
🟢 New in Current Filing
If we fail to responsibly use and protect data, or if such data is found to be inaccurate or unreliable, our business and customers could suffer adverse consequences.
🔒
🔴 No Match in Current Filing
The health benefits industry is subject to negative publicity, which could adversely affect our business, cash flows, financial condition and results of operations.
🔒
🟡 Modified
The failure to effectively maintain and upgrade our information systems, or the availability and integrity of our data, could adversely affect our business.
🔒
🟡 Modified
There are various risks associated with providing health benefits and other healthcare diversified products and services.
🔒
🟡 Modified
We face intense competition to attract and retain associates. Further, managing key executive succession and retention is critical to our success.
🔒
🟡 Modified
A significant reduction in the enrollment in our health benefits programs, pharmacy services or diversified products and services, particularly in states where we have large regional concentrations, could have an adverse effect on our business, cash flows, financial condition and results of operations.
🔒
🟡 Modified
We also face other risks that could adversely affect our business, financial condition or results of operations, which include:
🔒
🟡 Modified
Our pharmacy services business and pharmacy related operations are subject to risks and uncertainties that are in addition to those we face in our core healthcare business.
🔒